Experts working with you to create, fund, launch, and develop successful Biotech companies and programs
Our mission is to provide high value strategic analysis to biotechnology companies and their founders, their investors and their leadership. We focus on creating strategies to advance your programs, attract funding, accelerate asset momentum, driving value creation and successful corporate development.
Our network has world-class experience spanning diverse therapeutic areas including Neurology, Inflammation, Autoimmunity, Fibrosis, Solid Tumors, Hematological Cancers, Cardiovascular Disease, Asthma and Allergy, Osteoarthritis, Metabolic Diseases and many rare diseases. The list of specific diseases we cover is very comprehensive.
Our expertise covers all current drug classes, encompassing bench to clinic development of oral small molecule therapeutics, peptides and novel scaffolds, monoclonal antibodies, antibody-drug conjugates (ADC), immunotherapeutics, antibody fragments and protein fusions, and nucleotide-based therapeutics.
- Novel Immunotherapeutic Approaches to the Treatment of Cancer: Drug Development and Clinical Application (Jun 8, 2016)
- Inaugural International Cancer Immunotherapy Conference: Translating Science into Survival (Sep 9, 2015)
- SugarCone Biotech will be at the International Cancer Immunotherapy Conference: Translating Science into Survival 2015 (Aug 31, 2015)